62. Sampson JH, Archer GE, Mitchell DA, Heimberger AB, Herndon JE, 2nd, Lally -Goss D, McGehee- Norman S, Paolino A, Reardon DA, Friedman AH, Friedman HS, Bigner DD. An epidermal growth factor receptor variant III -targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme. Mol Cancer Ther.